Prodeon Medical, Inc., Announces Randomization in the Expander-2 Pivotal Clinical Trial Evaluating the Company’s Investigational Treatment for Lower Urinary Tract Symptoms Associated to Benign Prostatic Hyperplasia

SUNNYVALE, Calif., Sept. 26, 2022 /PRNewswire/ — Prodeon Medical, Inc., a medical device company developing an investigational outpatient treatment for lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH) today announced the randomization of the first…